U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. GDUFA III Reauthorization Negotiation Sessions
  1. Development & Approval Process | Drugs

GDUFA III Reauthorization Negotiation Sessions

In accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act), the Food and Drug Administration (FDA) held negotiations with the generic drug industry on the reauthorization of the Generic Drug User Fee Amendments of 2017 (GDUFA) program. The FDA publishes all negotiation meeting minutes on this website.

FDA-Industry Negotiations Meeting Minutes

Back to Top